CDKN1A and glioblastoma: Senescence in two primary GBM cell lines (primary adherent GBM cell PGC62 and GBM stem-like cell GSC0117, Table S4) was induced by 200 nM Doxorubicin treatment and confirmed by the expression validation of two well-recognized senescence markers, SA-β-gal and P21.